Insights

Lean Biotech With 11–50 employees and reported revenue of $1–10 million, InMed may value cost-effective services that reduce operational burden, accelerate research, or support a small team across multiple development programs.

Pipeline Support InMed is advancing small molecule programs for Alzheimer’s, ocular, and dermatological conditions. Vendors offering preclinical research, drug development, clinical planning, or regulatory expertise may be relevant as these programs progress.

Cannabinoid Manufacturing Through subsidiary BayMedica, InMed manufactures, develops, and commercializes rare cannabinoids and related analogs. This creates potential needs in production scale-up, quality systems, sourcing, distribution, and commercialization.

Research Visibility The company planned to present new INM-901 preclinical data at the 2025 Alzheimer’s Association International Conference and has added prominent Alzheimer’s experts to its advisory board. Scientific communications, data management, and partnership support may align with these priorities.

Funding And Governance InMed disclosed an expected CAD 10 million standby equity purchase and appointed two directors in October 2025. These developments may create opportunities for investor relations, financial operations, governance, and strategic partnership services.

Similar companies to InMed Pharmaceuticals

InMed Pharmaceuticals Tech Stack

InMed Pharmaceuticals uses 8 technology products and services including LinkedIn Ads, Matomo, Amazon Web Services, and more. Explore InMed Pharmaceuticals's tech stack below.

Media & News

InMed Pharmaceuticals's Email Address Formats

InMed Pharmaceuticals uses at least 3 email formats:
InMed Pharmaceuticals Email FormatsExamplePercentage
FLast@inmedpharma.comJDoe@inmedpharma.com
78%
First@inmedpharma.comJohn@inmedpharma.com
14%
Last@inmedpharma.comDoe@inmedpharma.com
8%

Frequently Asked Questions

What is InMed Pharmaceuticals's phone number?

Minus sign iconPlus sign icon
You can contact InMed Pharmaceuticals's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is InMed Pharmaceuticals's stock symbol?

Minus sign iconPlus sign icon
InMed Pharmaceuticals is a publicly traded company; the company's stock symbol is INM.

What is InMed Pharmaceuticals's official website and social media links?

Minus sign iconPlus sign icon
InMed Pharmaceuticals's official website is inmedpharma.com and has social profiles on LinkedIn.

How much revenue does InMed Pharmaceuticals generate?

Minus sign iconPlus sign icon
As of October 2026, InMed Pharmaceuticals's annual revenue is estimated to be $1M - $10M.

What is InMed Pharmaceuticals's SIC code and NAICS code?

Minus sign iconPlus sign icon
InMed Pharmaceuticals's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does InMed Pharmaceuticals have currently?

Minus sign iconPlus sign icon
As of October 2026, InMed Pharmaceuticals has approximately 17 employees across 2 continents, including North America and Asia. Key team members include Ceo + President, Director: E. A. A., Chief Operating Officer & Svp Cmc: M. W. and Vp Of Preclinical R&d: E. H. Explore InMed Pharmaceuticals's employee directory with LeadIQ.

What industry does InMed Pharmaceuticals belong to?

Minus sign iconPlus sign icon
InMed Pharmaceuticals operates in the Biotechnology Research industry.

What technology does InMed Pharmaceuticals use?

Minus sign iconPlus sign icon
InMed Pharmaceuticals's tech stack includes LinkedIn Ads, Matomo, Amazon Web Services, Usercentrics, Drupal, Shopify, Microsoft 365 and Brevo.

What is InMed Pharmaceuticals's email format?

Minus sign iconPlus sign icon
InMed Pharmaceuticals's email format typically follows the pattern of FLast@inmedpharma.com. Find more InMed Pharmaceuticals email formats with LeadIQ.
InMed Pharmaceuticals logo

InMed Pharmaceuticals

Biotechnology ResearchBritish Columbia, Canada11-50 Employees

InMed Pharmaceuticals is a small biotechnology company based in Vancouver, British Columbia, focused on developing proprietary small molecule drug candidates that target the CB1 and CB2 receptors. Its pipeline includes three programs addressing Alzheimer's disease, ocular conditions, and dermatological indications. The company also operates BayMedica, its subsidiary, which is involved in the manufacturing, development, and commercialization of products based on rare cannabinoids and their proprietary small molecule drug analogs.

The firm operates in the biotechnology research sector, focusing on cannabinoid-based therapeutics for conditions with high unmet medical needs. Its activities are conducted through a blend of internal programs and its BayMedica subsidiary. A recent development is the appointment of John Bathery to its board of directors in October 2025.

Section iconCompany Overview

Phone number
SIC Code
8731 - Commercial Physical and Biological Research
Stock Symbol
INM
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
11-50

Section iconFunding & Financials

  • $1M - $10M

    InMed Pharmaceuticals's revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.